Biohaven Ltd. Reports Q2 2026 Financial Results

What Happened
Biohaven Ltd. announced its financial results for the second quarter ended June 30, 2026 via a press release dated August 10, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8‑K filing (filed Aug 10, 2026), and the filing was signed by CFO Matthew Buten.

Key Details

• Filing date: August 10, 2026; reporting period: quarter ended June 30, 2026.
• The press release with Q2 2026 results is furnished as Exhibit 99.1 to the Form 8‑K and is incorporated by reference.
• Form signed by Chief Financial Officer Matthew Buten.
• The cover page is provided in Inline XBRL format (Exhibit 104).

Why It Matters
This 8‑K notifies investors that Biohaven has released its quarterly earnings and related financial information. Retail investors should review the furnished press release for specifics on revenue, earnings (or loss), guidance changes, and operational updates that could affect the stock. Because the 8‑K furnishes — rather than files — the press release, readers should consult the exhibit itself for the detailed figures and management commentary.